Gan & Lee Pharmaceuticals

E3F02
China Mainland
Company Profile
  • Year Established: 1998
  • Total Number of Staff: more than 1000
  • Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Reputation,Quality Service
  • Business Type: Manufacturer
  • R&D Capacity: OEM,Own Brand
  • Annual Turnover(USD) : More than 99,999,999
  • Main Sales Markets : Central/South America,Asia,Middle East

Founded in 1998, Gan & Lee Pharmaceuticals is a leading pharmaceutical company in China specializing in the development, production, and commercialization of recombinant insulin analogs and injection pens, and aiming to expand its reach globally. Headquartered in Beijing, Gan & Lee has an industrial park of about 200,000 square meters and nearly 2800 employees. With the aim of revitalizing China’s pharmaceutical industry and moving forward to advancing its goal of becoming a world-class pharmaceutical company, Gan & Lee will also take an active part in developing new chemical entities and biologics to treat various forms of cardiovascular disease, metabolic diseases, cancer, and other therapeutic areas. Please reach out to info@ganlee.com for business inquiries.

Year Established: 1998

Total Number of Staff: more than 1000

Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Reputation,Quality Service

Business Type: Manufacturer

R&D Capacity: OEM,Own Brand

Annual Turnover(USD) : More than 99,999,999

Main Sales Markets : Central/South America,Asia,Middle East

Top Products
Copyright 2006-2021 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
Powered by
×